Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
There are well-documented examples in the literature of where determining the genetic aetiology of a disorder has provided insights into important regulatory pathways and protein interactions, and, more recently, has led to improved treatment options for patients. The studies of monogenic forms of b...
主要な著者: | Gloyn, A, Tribble, N, van de Bunt, M, Barrett, A, Johnson, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2008
|
類似資料
-
Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
著者:: Gloyn, A, 等
出版事項: (2007) -
Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
著者:: Valentinova, L, 等
出版事項: (2011) -
Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
著者:: Gasperikova, D, 等
出版事項: (2008) -
Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
著者:: Christesen, H, 等
出版事項: (2008) -
Identification of a Novel beta-Cell Glucokinase (GCK) Promoter Mutation (-71G > C) That Modulates GCK Gene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans
著者:: Gasperikova, D, 等
出版事項: (2009)